Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bolli

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
British Journal of Clinical Pharmacology|January 1, 1984
Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patientsP Van Brummelen, P Bolli, M I Koolen, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Antihypertensive treatment using calcium antagonists in combination with captopril rather than diureticsR M Brouwer, P Bolli, P Erné, et al.
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
Prazosin: preliminary clinical and pharmacological observationsP Bolli, A J Wood, E L Phelan, et al.
The American Journal of Physiology|September 1, 1979
A method of intrarenal blood flow measurement using xenon-133 in the intact ratT J Butt, P Bolli, D R Jones, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1987
Electrocardiographic changes during antihypertensive therapy in the International Prospective Primary Prevention Study in HypertensionP Bolli, F Burkart, K Vesanen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 20, 1999
Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of CanadaE Burgess, R Lewanczuk, P Bolli, et al.
Journal of Clinical Hypertension|September 1, 1986
Dose initiation of calcium antagonists in the treatment of hypertensionF B Müller, P Erne, M Hotz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Plasma lipid fractions during bopindolol treatment in hypertensive patientsP van Brummelen, P Bolli, M I Koolen, et al.
The American Journal of Medicine|December 15, 1986
Calcium antagonists and the second drug for hypertensive therapyF B Müller, P Bolli, L Linder, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Free calcium response to adrenaline in platelets of normal and hypertensive (untreated and treated) subjectsP Erne, T J Resink, P Bolli, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Clinical Pharmacology|January 1, 1984
Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patientsP Van Brummelen, P Bolli, M I Koolen, et al.
Journal of Cardiovascular Pharmacology|January 1, 1985
Antihypertensive treatment using calcium antagonists in combination with captopril rather than diureticsR M Brouwer, P Bolli, P Erné, et al.
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
Prazosin: preliminary clinical and pharmacological observationsP Bolli, A J Wood, E L Phelan, et al.
The American Journal of Physiology|September 1, 1979
A method of intrarenal blood flow measurement using xenon-133 in the intact ratT J Butt, P Bolli, D R Jones, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1987
Electrocardiographic changes during antihypertensive therapy in the International Prospective Primary Prevention Study in HypertensionP Bolli, F Burkart, K Vesanen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 20, 1999
Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of CanadaE Burgess, R Lewanczuk, P Bolli, et al.
Journal of Clinical Hypertension|September 1, 1986
Dose initiation of calcium antagonists in the treatment of hypertensionF B Müller, P Erne, M Hotz, et al.
Journal of Cardiovascular Pharmacology|January 1, 1986
Plasma lipid fractions during bopindolol treatment in hypertensive patientsP van Brummelen, P Bolli, M I Koolen, et al.
The American Journal of Medicine|December 15, 1986
Calcium antagonists and the second drug for hypertensive therapyF B Müller, P Bolli, L Linder, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Free calcium response to adrenaline in platelets of normal and hypertensive (untreated and treated) subjectsP Erne, T J Resink, P Bolli, et al.
Pageof 13